Your browser doesn't support javascript.
loading
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial.
Diamantidis, Clarissa J; Bosworth, Hayden B; Oakes, Megan M; Davenport, Clemontina A; Pendergast, Jane F; Patel, Sejal; Moaddeb, Jivan; Barnhart, Huiman X; Merrill, Peter D; Baloch, Khaula; Crowley, Matthew J; Patel, Uptal D.
Afiliación
  • Diamantidis CJ; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Division of Nephrology, Duke University School of Medicine, Durham, NC, United States. Electronic address: clarissa.diamantidis@duke.edu.
  • Bosworth HB; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Center for Health Services Research in Primary Medicine, Durham VAMC, United States; Department of Population Health Science, Duke University School of Medicine, Durham, NC, United States.
  • Oakes MM; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Department of Population Health Science, Duke University School of Medicine, Durham, NC, United States.
  • Davenport CA; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.
  • Pendergast JF; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.
  • Patel S; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States.
  • Moaddeb J; Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, United States; Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC, United States.
  • Barnhart HX; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.
  • Merrill PD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.
  • Baloch K; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.
  • Crowley MJ; Division of Endocrinology, Duke University School of Medicine, Durham, NC, United States.
  • Patel UD; Division of Nephrology, Duke University School of Medicine, Durham, NC, United States; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States; Gilead Sciences, Inc, Foster City, CA, United States.
Contemp Clin Trials ; 69: 28-39, 2018 06.
Article en En | MEDLINE | ID: mdl-29649631
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Educación del Paciente como Asunto / Telemedicina / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Hipertensión Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Educación del Paciente como Asunto / Telemedicina / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Hipertensión Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2018 Tipo del documento: Article